Cytokine receptor signaling activates an IKK-dependent phosphorylation of PUMA to prevent cell death

P53-upregulated modifier of apoptosis (PUMA), a pro-apoptotic member of the Bcl-2 family, is transcriptionally activated by p53 and is a key effector of p53-dependent apoptosis. We show that PUMA protein is subject to rapid post-translational regulation by phosphorylation at a conserved residue, ser...

Full description

Saved in:
Bibliographic Details
Published inCell death and differentiation Vol. 19; no. 4; pp. 633 - 641
Main Authors Sandow, J J, Jabbour, A M, Condina, M R, Daunt, C P, Stomski, F C, Green, B D, Riffkin, C D, Hoffmann, P, Guthridge, M A, Silke, J, Lopez, A F, Ekert, P G
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.04.2012
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:P53-upregulated modifier of apoptosis (PUMA), a pro-apoptotic member of the Bcl-2 family, is transcriptionally activated by p53 and is a key effector of p53-dependent apoptosis. We show that PUMA protein is subject to rapid post-translational regulation by phosphorylation at a conserved residue, serine 10, following serum or interleukin-3 (IL-3) stimulation. Serine 10 is not within the Bcl-2 homology (BH3) domain, and PUMA phosphorylated at serine 10 retained the ability to co-immunoprecipitate with antiapoptotic Bcl-2 family members. However, phosphorylated PUMA was targeted for proteasomal degradation indicating that it is less stable than unphosphorylated PUMA. Importantly, we identified IKK1/IKK2/Nemo as the kinase complex that interacts with and phosphorylates PUMA, thereby also demonstrating that IL-3 activates NF κ B signaling. The identification and characterization of this novel survival pathway has important implications for IL-3 signaling and hematopoietic cell development.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1350-9047
1476-5403
1476-5403
DOI:10.1038/cdd.2011.131